UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017429
Receipt number R000020111
Scientific Title Observational study For Investigating the ability of Recuperation of work/ house work State with adalimumab treatment in RA patients in tohoku
Date of disclosure of the study information 2015/05/07
Last modified on 2015/05/06 12:22:55

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Observational study For Investigating the ability of Recuperation of work/ house work State with adalimumab treatment in RA patients in tohoku

Acronym

AT HOME study

Scientific Title

Observational study For Investigating the ability of Recuperation of work/ house work State with adalimumab treatment in RA patients in tohoku

Scientific Title:Acronym

AT HOME study

Region

Japan


Condition

Condition

rheumatoid arthritis

Classification by specialty

Medicine in general Clinical immunology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the efficacy and safety, including improvement in paid work and housework, of treatment with adalimumab in patients with rheumatoid arthritis in tohoku area

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Phase IV


Assessment

Primary outcomes

Change in percent overall work impairment (at the last observation, up to week72) in paid workers, by the Work Productivity and Activity Impairment Questionnaire (WPAI)

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >

Gender

Male and Female

Key inclusion criteria

(1)Age => 20 years and 75<years at registration
(2)Diagnosis of rheumatoid arthritis according to the American College of Rheumatology ACR criteria
(3) Patients who want to be treated with adalimumab and MTX
(4)Consent to study participation has been obtained in writing from the patient personally

Key exclusion criteria

(1)Patients who pregnant
(2)Patients who cannot use the drug in this study by contraindication.
(3)The principal investigator or co-investigator has determined that the participation of the patient in the study would not be appropriate

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Tomonori ISHII

Organization

Tohoku university hospital

Division name

Crieto

Zip code


Address

1-1, seiryocho, aobaku, senndai

TEL

022-717-7165

Email

tishii@med.tohoku.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Tomonori ISHII

Organization

Tohoku university hospital

Division name

Crieto

Zip code


Address

1-1, seiryocho, aobaku, senndai

TEL

022-717-7165

Homepage URL


Email

tishii@med.tohoku.ac.jp


Sponsor or person

Institute

Tohoku uviversity hospital

Institute

Department

Personal name



Funding Source

Organization

ichinohazama academy

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 05 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2015 Year 03 Month 31 Day

Date of IRB


Anticipated trial start date

2015 Year 04 Month 25 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

pre obxervation period


Management information

Registered date

2015 Year 05 Month 06 Day

Last modified on

2015 Year 05 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020111


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name